Central nervous system hematopoietic neoplasm
diseaseOn this page
Also known as central nervous system haematopoietic and lymphoid system neoplasmcentral nervous system haematopoietic neoplasmscentral nervous system haematopoietic tumourcentral nervous system hematopoietic and lymphoid system neoplasmcentral nervous system hematopoietic neoplasmscentral nervous system hematopoietic tumorCNS haematopoietic neoplasmCNS haematopoietic tumourCNS hematopoietic neoplasmCNS hematopoietic tumorhaematopoietic and lymphoid system neoplasm of central nervous systemhaematopoietic neoplasm of central nervous systemhaematopoietic neoplasm of CNShaematopoietic neoplasm of the central nervous systemhaematopoietic neoplasm of the CNShaematopoietic tumour of central nervous systemhaematopoietic tumour of the central nervous systemhematopoietic and lymphoid system neoplasm of central nervous systemhematopoietic neoplasm of central nervous system
Summary
Central nervous system hematopoietic neoplasm (MONDO:0003641) is a cancer. A subtype of central nervous system neoplasm — broader associated-gene and molecular evidence is on the parent page (see Disease family below).
At a glance
- Classification: Cancer
Clinical features
No curated clinical features (Orphanet) for this disease.
Identifiers
Disease identifiers
| Field | Value |
|---|---|
| Canonical name | central nervous system hematopoietic neoplasm |
| Mondo ID | MONDO:0003641 |
| DOID | DOID:5772 |
| NCIT | C5503 |
| UMLS | C1332882 |
| MedGen | 234101 |
| GARD | 0023597 |
| Anatomy (UBERON) | UBERON:0001017 |
| Is cancer (heuristic) | yes |
Also known as: central nervous system haematopoietic and lymphoid system neoplasm · central nervous system haematopoietic neoplasms · central nervous system haematopoietic tumour · central nervous system hematopoietic and lymphoid system neoplasm · central nervous system hematopoietic neoplasm · central nervous system hematopoietic neoplasms · central nervous system hematopoietic tumor · CNS haematopoietic neoplasm · CNS haematopoietic tumour · CNS hematopoietic neoplasm · CNS hematopoietic tumor · haematopoietic and lymphoid system neoplasm of central nervous system · haematopoietic neoplasm of central nervous system · haematopoietic neoplasm of CNS · haematopoietic neoplasm of the central nervous system · haematopoietic neoplasm of the CNS · haematopoietic tumour of central nervous system · haematopoietic tumour of the central nervous system · hematopoietic and lymphoid system neoplasm of central nervous system · hematopoietic neoplasm of central nervous system (+7 more)
Disease family
This is a subtype of central nervous system neoplasm. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.
Classification path: disease › human disease › disease by body system or component › nervous system disorder › central nervous system disorder › central nervous system neoplasm › central nervous system hematopoietic neoplasm
Related subtypes (9): central nervous system organ benign neoplasm, autonomic nervous system neoplasm, optic nerve neoplasm, central nervous system cancer, central nervous system germ cell tumor, epidural abscess, tumor of meninges, brain neoplasm, spinal cord neoplasm
Subtypes (4): central nervous system leukemia, intracranial cavernous angioma, primary central nervous system lymphoma, pituitary gland basophil adenoma
Genetics & variants
GWAS landscape
No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.
Variant details and genetic-evidence tiers
No tiered GWAS variants or ClinVar records for this disease.
Genes & proteins
No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).
Function
No pathway enrichment — requires an associated-gene cohort.
Therapeutics
No druggable-target or therapeutic data for this disease’s cohort.
Clinical trials & evidence
Clinical trials
Clinical trials: 0.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.